Loading viewer...
conference
Format: PDF conference
Presentation delivered at the 41st Annual J.P. Morgan Healthcare Conference in January 2023. The company is advancing development programs across multiple therapeutic areas including Alzheimer's, Parkinson's, Migraine, and Hypercholesterolemia, with discussions of discovery, research activities, and anticipated clinical development timelines for product candidates.
investor_presentation
18 Pages
conference
38 Pages
aTyr Pharma
Indiana Pregnancy Promise Program 2024 IHCP Roadshow
conferenceconference
12 Pages
Indiana Family and Social Services Administration (FSSA)
Genco Shipping & Trading 2023 Jefferies Industrials Conference
conferenceconference
42 Pages
Genco Shipping & Trading